Petal Public Market Comparables
Find the most relevant public market comparables for Petal, including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
There are multiple companies named Petal. One is a credit card company that offers credit cards to consumers, using alternative data sources to assess creditworthiness. Another is a healthcare technology company providing a real-time healthcare orchestration platform to improve access to care and streamline healthcare systems.
Business Model
The credit card company's business model involves issuing credit cards and earning revenue from interest and fees. The healthcare technology company's business model is based on providing a software platform as a service (SaaS) to healthcare organizations.
Target Customers
The credit card company targets consumers, particularly those with limited or no credit history. The healthcare company targets health authorities, healthcare delivery organizations, clinics, and healthcare professionals.
Specific Focus
Alternative credit scoring and Real-time Healthcare Orchestration
Location
Quebec, Quebec
CEO
Patrice Gilbert
Industry
Life sciences
Sub Sector
Fintech (Credit Cards) and Healthcare IT
3yr Revenue Growth
267%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Petal in the Financial Services and Healthcare Technology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Petal? Our platform provides detailed analysis of Petal's competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Petal compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Petal Compset
As a leading player in the Life sciences industry within the Financial Services and Healthcare Technology sector, Petal operates in the specialized Fintech (Credit Cards) and Healthcare IT sub-sector. Understanding how Petal compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Fintech (Credit Cards) and Healthcare IT space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Nova Credit
Fintech • Fintech
Nova Credit is a credit infrastructure and analytics company that enables businesses to grow responsibly by harnessing alternative credit data. They provide cross-border credit reporting and solutions for assessing borrower risk based on consumer bank account data and income verification.
Upgrade
Financial Technology (Fintech) • Fintech
Upgrade is a financial technology company that provides access to affordable and responsible credit to mainstream consumers through cards and personal loans, offers free credit monitoring and education tools, and provides access to online checking and savings accounts with no monthly fees.
Akido Labs
Healthcare • Life sciences
Akido Labs is an AI and care delivery company reimagining healthcare with a focus on using AI to improve access and quality of care. They have developed ScopeAI, an AI system that increases clinical capacity and improves healthcare access, aiming to address physician shortages and improve patient care.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Petal and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free